Every Form 4 that Innovex International, Inc. (INVX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow INVX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INVX filings page.
Innovex International, Inc. (INVX) reported that Chief Executive Officer Anderson Adam had 13,463 shares of common stock withheld on September 6, 2026 to satisfy tax withholding obligations upon the release of restricted stock units. These shares were not sold in the open market. After this withholding, Adam directly holds 491,790 shares of Innovex common stock.
Innovex International, Inc. (INVX) reported that Reddout Mark, President of North America, had 5,049 shares of common stock withheld on September 6, 2026 to satisfy tax withholding obligations arising from the release of restricted stock units. After this tax-withholding disposition, he holds 119,263 shares of Innovex common stock directly, and no Rule 10b5-1 plan is reported.
Innovex International, Inc. (INVX) reported that its Chief Financial Officer, Reed Kendal, had 5,049 shares of common stock withheld on September 6, 2026 to satisfy tax withholding obligations upon the release of restricted stock units. The withholding was priced at $30.07 per share, and Kendal now directly holds 209,434 shares of Innovex common stock. No Rule 10b5-1 trading plan is reported.
Innovex International, Inc. (INVX) had multiple affiliated investment funds report trades in its common stock. On 2026-08-10, funds associated with Amberjack Capital and Intervale Capital reported an aggregate net sale of 4,954,467 shares of common stock at $28.71 per share in an underwritten secondary offering to Barclays Capital Inc. One fund, Intervale Capital Fund III, L.P., is reported as acquiring 45,533 shares at the same price. These positions are held indirectly through various limited partnerships and general partners, which exercise voting and dispositive power over the shares. Following the transactions, Amberjack Capital Fund II, L.P. held 13,164,573 shares and Innovex Co-Invest Fund II, L.P. held 3,073,822 shares indirectly.
Innovex International, Inc. insiders affiliated with Amberjack Capital Partners and Innovex Co-Invest reported net sales of 5,000,000 shares of common stock on 2026-08-10. The shares were sold indirectly by several investment funds in an underwritten secondary offering at $28.71 per share to Barclays Capital Inc., pursuant to a Rule 10b5-1 trading plan. After these sales, Amberjack Capital Fund II, L.P. reported holding 13,164,573 shares, with other affiliated funds retaining smaller positions, and Jason Turowsky disclaimed beneficial ownership beyond his pecuniary interests.
Innovex International, Inc. executive Mark Reddout, President of North America, reported selling 10,000 shares of Common Stock on August 4, 2026 at $30.00 per share. The sale is described as an open market or private transaction under a Rule 10b5-1 plan adopted on March 2, 2026. Following this trade, he directly holds 124,312 shares.
Innovex International, Inc. executive Mark Reddout, President of North America, reported an open-market sale of 10,750 shares of common stock at $28.00 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 2, 2026.
After this transaction, Reddout continues to hold 134,312 shares of Innovex common stock directly, so he retains a significant ongoing stake in the company despite the sale being a net reduction in his holdings.
Innovex International, Inc. Chief Financial Officer Reed Kendal reported a tax-withholding share disposition tied to restricted stock units. On the RSU release date, 3,349 shares of Common Stock were withheld at $24.79 per share to satisfy tax obligations. Following this non-market transaction, Kendal directly holds 214,483 Innovex shares.
Innovex International, Inc. executive Mark Reddout, President of North America, had 3,349 shares of common stock withheld on April 6, 2026 to satisfy tax withholding obligations tied to the release of restricted stock units. After this tax-withholding disposition, he directly holds 145,062 shares of Innovex common stock, indicating this was a compensation-related, non–open-market event rather than a discretionary share sale.
Innovex International, Inc. Chief Executive Officer Adam Anderson reported an automatic share disposition related to equity compensation. On the release of restricted stock units, 8,929 shares of common stock were withheld at a price of $24.79 per share to satisfy tax withholding obligations. After this non-market, tax-related transaction, Anderson directly holds 505,253 shares of Innovex common stock.
Innovex International, Inc. Chief Financial Officer Reed Kendal reported a routine share withholding related to equity compensation. On April 6, 2026, 2,072 shares of common stock were withheld at $24.79 per share to cover tax obligations upon the release of restricted stock units. After this non-market tax-withholding disposition, Kendal directly holds 215,760 shares of Innovex common stock.
Innovex International, Inc. President of North America Mark Reddout reported a routine tax-related share disposition. On the release of restricted stock units, he had 2,072 shares of common stock withheld at an implied value of $24.79 per share to satisfy tax withholding obligations. After this non‑market transaction, he continues to hold 146,339 shares of Innovex common stock directly.
Innovex International, Inc. director Benjamin Matthew Fink reported an equity award of common stock. He acquired 5,465 shares of common stock on a grant/award basis at a stated price of $0.00 per share. Following this award, his directly held common stock position increased to 21,376 shares.
Anderson Adam reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. reported that Chief Executive Officer Adam Anderson received a grant of 47,438 shares of common stock on February 27, 2026 at a stated price of $0.00 per share. Following this award, he directly owns 514,182 common shares.
Innovex International, Inc. director Jupp Terence Bartlett reported an award of 5,465 shares of common stock on February 27, 2026. The shares were acquired as a grant at a stated price of $0.00 per share, bringing his directly held stake to 89,832 common shares.
Innovex International director Sedita Angie reported a stock grant. On this Form 4, Sedita received 5,465 shares of Innovex International, Inc. common stock as a grant or award at no cost. After this acquisition, Sedita directly holds a total of 29,881 common shares.
Innovex International, Inc. director John Lovoi received a stock award of 5,465 shares of common stock on February 27, 2026, recorded as a grant or other acquisition at a stated price of $0.00 per share. After this award, his directly held common stock ownership increased to 101,427 shares.
Reddout Mark reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. reported that President of North America Mark Reddout received a grant of 18,975 shares of common stock on February 27, 2026. The award was recorded at a price of $0.00 per share, bringing his directly held common stock to 148,411 shares after the transaction.
Black Bonnie S. reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. director Bonnie S. Black received a grant of 5,465 shares of common stock on February 27, 2026 at no stated purchase price. Following this award, she directly holds a total of 35,844 common shares.
Reed Kendal reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. reported that Chief Financial Officer Reed Kendal received a grant of 18,975 shares of common stock on February 27, 2026 as a stock award with no purchase price. Following this award, his directly owned holdings total 217,832 common shares.
Amberjack-affiliated investment funds sold 6,612,500 shares of Innovex International common stock in an underwritten secondary offering. The shares were sold at a public offering price of $25.75 per share, and the selling funds received $24.59125 per share after underwriting discounts.
The transactions were reported as indirect sales by entities including Amberjack Capital Fund II, Innovex Co-Invest Fund II, Innovex Co-Invest Fund, Intervale Capital Fund II, Intervale Capital Fund II-A, and Intervale Capital Fund III. Footnotes state that Amberjack Management and related general partners may be deemed beneficial owners, while managing partner Jason Turowsky disclaims beneficial ownership beyond his economic interest.
Innovex International, Inc. reported that investment funds affiliated with Amberjack Capital Partners sold a total of 6,612,500 shares of Innovex common stock in open-market-style transactions tied to an underwritten secondary offering. The shares were sold at a public price of $25.75 per share, with the funds receiving $24.59125 per share after underwriting discounts. Individual transactions included 4,902,244 shares sold by Amberjack Capital Fund II, L.P., 1,144,635 shares by Innovex Co-Invest Fund II, L.P., 271,279 shares by Innovex Co-Invest Fund, L.P., and smaller blocks by Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., and Intervale Capital Fund III, L.P. After these sales, Amberjack Capital Fund II, L.P. held 16,871,374 Innovex shares, while Innovex Co-Invest Fund II, L.P. held 3,939,330 shares and Innovex Co-Invest Fund, L.P. held 933,624 shares.
Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of common stock. On February 24, 2026, he sold 18,837 shares of Innovex common stock at $28.50 per share in a transaction classified as a sale in the open market or a private transaction.
The filing states that all shares in this trade were sold at the reported price and that the sales were made pursuant to a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025. After this transaction, Anderson’s directly held Innovex common stock position is 466,744 shares.
Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of company stock. On February 23, 2026, he sold 13,241 shares of common stock at $27.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.
After this transaction, Anderson directly owned 485,581 shares of Innovex International common stock. The filing specifies that all shares in this trade were sold at the stated price per share.
Innovex International, Inc. executive Mark Reddout, President of North America, reported selling 20,000 shares of common stock on January 14, 2026 at $25 per share. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). After this transaction, he directly beneficially owned 129,436 shares of Innovex International common stock.
Innovex International, Inc. (INVX) Chief Executive Officer and director Adam Anderson reported selling 13,241 shares of common stock on January 14, 2026. The sale, coded as an open market sale, was executed at a price of $25 per share and was carried out under a Rule 10b5-1 trading plan adopted on March 14, 2025, which is designed to pre-arrange trades. Following this transaction, Anderson directly beneficially owns 498,822 shares of Innovex common stock.
Innovex International, Inc. insider Adam Anderson, who serves as both Director and Chief Executive Officer, reported a stock transaction on 01/02/2026. He had 23,232 shares of Innovex common stock withheld at a price of $22.78 per share, classified under transaction code F, which is typically used for shares withheld to cover taxes. After this withholding related to the release of restricted stock units, Anderson beneficially owns 512,063 shares of Innovex common stock directly.
Innovex International, Inc. chief financial officer Kendal Reed reported an automatic share withholding related to equity compensation. On 01/02/2026, Reed had 8,026 shares of Innovex common stock withheld at a price of $22.78 per share, coded as transaction type "F," which typically reflects shares withheld to cover taxes.
After this tax-withholding event tied to the release of restricted stock units, Reed directly beneficially owned 198,857 shares of Innovex common stock. The filing was made as a single-person Form 4 and is a routine insider ownership update rather than an open-market purchase or sale.
Innovex International, Inc. executive Mark Reddout, President of North America, reported a routine equity award. On 12/15/2025, he received 40 shares of Innovex common stock at a price of $0, as part of a grant of 40 shares to every employee of the company. On the same date, 16 shares were disposed of at $22.77 per share, identified with transaction code "F", indicating shares withheld to cover taxes on the award. After these transactions, Reddout directly beneficially owned 149,436 shares of Innovex common stock.
Innovex International, Inc. disclosed an insider equity transaction by its Chief Financial Officer, Kendal Reed. On 12/15/2025, Reed reported activity in the company’s common stock, including an acquisition coded as an award and a related tax-withholding transaction. One entry shows 40 shares of common stock acquired at $0 per share, with beneficial ownership after the reported transactions at 206,883 shares held directly. Another entry reflects 16 shares disposed of at $22.77 per share, also leaving direct ownership at 206,883 shares.
The explanation states this award represents net shares after tax withholding as part of a grant of 40 shares of stock to every employee of the company. The filing is made by one reporting person in Reed’s capacity as an officer of Innovex International, serving as Chief Financial Officer.
Innovex International, Inc. director and Chief Executive Officer reported a small equity award and related tax withholding. On 12/15/2025, the insider received 40 shares of common stock at a stated price of $0. The filing notes this award reflects the net shares after tax withholding from a grant of 40 shares made to every company employee.
Also on 12/15/2025, 16 shares of common stock were disposed of at $22.77 with a transaction code of “F,” indicating shares withheld to cover taxes on the award. Following these transactions, the insider directly beneficially owns 535,295 shares of Innovex common stock.